Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Geographic Heterogeneity for Mismatch Repair Proteins Is Associated with Defects in DNA Repair.

Greenberg A, Kariv R, Solar I, Hershkovitz D.

Isr Med Assoc J. 2020 Jan;22(1):32-36.

2.

Iris-assisted terahertz field-induced second-harmonic generation in air.

Beer A, Hershkovitz D, Fleischer S.

Opt Lett. 2019 Nov 1;44(21):5190-5193. doi: 10.1364/OL.44.005190.

PMID:
31674964
3.

Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard.

Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, Mabjeesh NJ, Yossepowitch O, Mishani E, Even-Sapir E.

J Nucl Med. 2020 Apr;61(4):527-532. doi: 10.2967/jnumed.119.234187. Epub 2019 Sep 27.

PMID:
31562225
4.

Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.

Zinger A, Koren L, Adir O, Poley M, Alyan M, Yaari Z, Noor N, Krinsky N, Simon A, Gibori H, Krayem M, Mumblat Y, Kasten S, Ofir S, Fridman E, Milman N, Lübtow MM, Liba L, Shklover J, Shainsky-Roitman J, Binenbaum Y, Hershkovitz D, Gil Z, Dvir T, Luxenhofer R, Satchi-Fainaro R, Schroeder A.

ACS Nano. 2019 Oct 22;13(10):11008-11021. doi: 10.1021/acsnano.9b02395. Epub 2019 Sep 20.

PMID:
31503443
5.

Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211.

Golan T, Parikh R, Jacob E, Vaknine H, Zemser-Werner V, Hershkovitz D, Malcov H, Leibou S, Reichman H, Sheinboim D, Percik R, Amar S, Brenner R, Greenberger S, Kung A, Khaled M, Levy C.

Sci Signal. 2019 Jul 23;12(591). pii: eaav6847. doi: 10.1126/scisignal.aav6847.

PMID:
31337739
6.

Tumor-to-Tumor Metastasis of Colorectal Adenocarcinoma to Ovarian Cystadenofibroma: A Case Report and Review of the Literature.

Fahoum I, Brazowski E, Hershkovitz D, Aizic A.

Int J Gynecol Pathol. 2020 May;39(3):270-272. doi: 10.1097/PGP.0000000000000592.

PMID:
30882401
7.

Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.

Tordjman KM, Greenman Y, Ram Z, Hershkovitz D, Aizenstein O, Ariel O, Asa SL.

Endocr Pathol. 2019 Mar;30(1):74-80. doi: 10.1007/s12022-018-9562-3.

PMID:
30610567
8.

Pure sinusoidal photo-modulation using an acousto-optic modulator.

Tzang O, Hershkovitz D, Nagler A, Cheshnovsky O.

Rev Sci Instrum. 2018 Dec;89(12):123102. doi: 10.1063/1.5020796.

PMID:
30599569
9.

Mucor Appendicitis Resolution Following Surgical Excision without Antifungal Therapy.

Naor S, Sher O, Grisaru-Soen G, Levin D, Elhasid R, Geffen Y, Hershkovitz D, Aizic A.

Isr Med Assoc J. 2018 Sep;20(9):592-593. No abstract available.

10.

Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA.

Fahoum I, Forer R, Volodarsky D, Vulih I, Bick T, Sarji S, Bamberger Z, Ben-Izhak O, Sabo E, Hershberg R, Hershkovitz D.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818793653. doi: 10.1177/1533033818793653.

11.

68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study.

Kesler M, Levine C, Hershkovitz D, Mishani E, Menachem Y, Lerman H, Zohar Y, Shibolet O, Even-Sapir E.

J Nucl Med. 2018 Jul 12. pii: jnumed.118.214833. doi: 10.2967/jnumed.118.214833. [Epub ahead of print]

12.

PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.

Ghannam-Shahbari D, Jacob E, Kakun RR, Wasserman T, Korsensky L, Sternfeld O, Kagan J, Bublik DR, Aviel-Ronen S, Levanon K, Sabo E, Larisch S, Oren M, Hershkovitz D, Perets R.

Oncogene. 2018 Apr;37(17):2213-2224. doi: 10.1038/s41388-017-0040-z. Epub 2018 Jan 30.

PMID:
29379162
13.

Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.

Perets R, Greenberg O, Shentzer T, Semenisty V, Epelbaum R, Bick T, Sarji S, Ben-Izhak O, Sabo E, Hershkovitz D.

Oncologist. 2018 May;23(5):566-572. doi: 10.1634/theoncologist.2017-0467. Epub 2018 Jan 25.

14.

Proteolytic Nanoparticles Replace a Surgical Blade by Controllably Remodeling the Oral Connective Tissue.

Zinger A, Adir O, Alper M, Simon A, Poley M, Tzror C, Yaari Z, Krayem M, Kasten S, Nawy G, Herman A, Nir Y, Akrish S, Klein T, Shainsky-Roitman J, Hershkovitz D, Schroeder A.

ACS Nano. 2018 Feb 27;12(2):1482-1490. doi: 10.1021/acsnano.7b07983. Epub 2018 Jan 30.

15.

Synthetic Cells Synthesize Therapeutic Proteins inside Tumors.

Krinsky N, Kaduri M, Zinger A, Shainsky-Roitman J, Goldfeder M, Benhar I, Hershkovitz D, Schroeder A.

Adv Healthc Mater. 2018 May;7(9):e1701163. doi: 10.1002/adhm.201701163. Epub 2017 Dec 28.

16.

Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.

Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A, Hershkovitz D, Ram Z, Bokstein F.

World Neurosurg. 2018 Feb;110:e727-e737. doi: 10.1016/j.wneu.2017.11.105. Epub 2017 Nov 26.

PMID:
29183864
17.

Nanoparticles target early-stage breast cancer metastasis in vivo.

Goldman E, Zinger A, da Silva D, Yaari Z, Kajal A, Vardi-Oknin D, Goldfeder M, Schroeder JE, Shainsky-Roitman J, Hershkovitz D, Schroeder A.

Nanotechnology. 2017 Oct 27;28(43):43LT01. doi: 10.1088/1361-6528/aa8a3d. Epub 2017 Sep 5.

PMID:
28872058
18.

Correction: Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT.

Keller B, Zaidman I, Yousefi OS, Hershkovitz D, Stein J, Unger S, Schachtrup K, Sigvardsson M, Kuperman AA, Shaag A, Schamel WW, Elpeleg O, Warnatz K, Stepensky P.

J Exp Med. 2017 Jul 3;214(7):2165. doi: 10.1084/jem.2015111005242017c. Epub 2017 Jun 1. No abstract available.

19.

Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.

Simon E, Bick T, Sarji S, Shentzer T, Prinz E, Yehiam L, Sabo E, Ben-Izhak O, Hershkovitz D.

Oncotarget. 2017 Jul 11;8(28):45736-45749. doi: 10.18632/oncotarget.17399.

20.

Molecular and Morphometric Tools for Next-Generation Pathology Diagnosis of Colon Carcinoma.

Fisher Y, Hershkovitz D.

Isr Med Assoc J. 2016 Jul;18(7):426-432. Review. No abstract available.

21.

Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.

Rachman-Tzemah C, Zaffryar-Eilot S, Grossman M, Ribero D, Timaner M, Mäki JM, Myllyharju J, Bertolini F, Hershkovitz D, Sagi I, Hasson P, Shaked Y.

Cell Rep. 2017 Apr 25;19(4):774-784. doi: 10.1016/j.celrep.2017.04.005.

22.

Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.

Asor E, Stav MY, Simon E, Fahoum I, Sabo E, Ben-Izhak O, Hershkovitz D.

PLoS One. 2017 Mar 13;12(3):e0173760. doi: 10.1371/journal.pone.0173760. eCollection 2017.

23.

The antiangiogenic role of the pro-inflammatory cytokine interleukin-31.

Davidi S, Fremder E, Kan T, Raviv Z, Timaner M, Karin N, Hershkovitz D, Arohneim A, Shaked Y.

Oncotarget. 2017 Mar 7;8(10):16430-16444. doi: 10.18632/oncotarget.14857.

24.

Hairy cell leukemia-variant without typical morphology and with near-tetraploid DNA content.

Azoulay D, Sonkin V, Akria L, Rozano Gorelick A, Trakhtenbrot L, Hershkovitz D, Shaoul E, Rozen S, Dementiev E, Cohen HI, Suriu C, Braester A.

Cytometry B Clin Cytom. 2018 Jan;94(1):169-171. doi: 10.1002/cyto.b.21503. Epub 2017 Feb 6. No abstract available.

25.

Theranostic barcoded nanoparticles for personalized cancer medicine.

Yaari Z, da Silva D, Zinger A, Goldman E, Kajal A, Tshuva R, Barak E, Dahan N, Hershkovitz D, Goldfeder M, Roitman JS, Schroeder A.

Nat Commun. 2016 Nov 10;7:13325. doi: 10.1038/ncomms13325.

26.

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3.

Alishekevitz D, Gingis-Velitski S, Kaidar-Person O, Gutter-Kapon L, Scherer SD, Raviv Z, Merquiol E, Ben-Nun Y, Miller V, Rachman-Tzemah C, Timaner M, Mumblat Y, Ilan N, Loven D, Hershkovitz D, Satchi-Fainaro R, Blum G, Sleeman JP, Vlodavsky I, Shaked Y.

Cell Rep. 2016 Oct 25;17(5):1344-1356. doi: 10.1016/j.celrep.2016.09.083.

27.

Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.

Kurolap A, Armbruster A, Hershkovitz T, Hauf K, Mory A, Paperna T, Hannappel E, Tal G, Nijem Y, Sella E, Mahajnah M, Ilivitzki A, Hershkovitz D, Ekhilevitch N, Mandel H, Eulenburg V, Baris HN.

Am J Hum Genet. 2016 Nov 3;99(5):1172-1180. doi: 10.1016/j.ajhg.2016.09.004. Epub 2016 Oct 20.

28.

Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT.

Keller B, Zaidman I, Yousefi OS, Hershkovitz D, Stein J, Unger S, Schachtrup K, Sigvardsson M, Kuperman AA, Shaag A, Schamel WW, Elpeleg O, Warnatz K, Stepensky P.

J Exp Med. 2016 Jun 27;213(7):1185-99. doi: 10.1084/jem.20151110. Epub 2016 May 30. Erratum in: J Exp Med. 2017 Jun 1;:.

29.

Vestibular evoked myogenic potentials and motion sickness medications.

Tal D, Shemy S, Kaminski-Graif G, Wiener G, Hershkovitz D.

Clin Neurophysiol. 2016 Jun;127(6):2350-4. doi: 10.1016/j.clinph.2016.03.010. Epub 2016 Mar 19.

PMID:
27178852
30.

Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection.

Ostrow SL, Simon E, Prinz E, Bick T, Shentzer T, Nagawkar SS, Sabo E, Ben-Izhak O, Hershberg R, Hershkovitz D.

Sci Rep. 2016 Feb 23;6:21927. doi: 10.1038/srep21927.

31.

Subclonality for BRAF Mutation in Papillary Thyroid Carcinoma Is Associated With Earlier Disease Stage.

Finkel A, Liba L, Simon E, Bick T, Prinz E, Sabo E, Ben-Izhak O, Hershkovitz D.

J Clin Endocrinol Metab. 2016 Apr;101(4):1407-13. doi: 10.1210/jc.2015-4031. Epub 2016 Feb 2.

PMID:
26835544
32.

Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller Lesions.

Nagawkar SS, Abu-Funni S, Simon E, Bick T, Prinz E, Sabo E, Ben-Izhak O, Hershkovitz D.

Pancreas. 2016 Jul;45(6):876-81. doi: 10.1097/MPA.0000000000000562.

PMID:
26646269
33.

Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.

Baris HN, Barnes-Kedar I, Toledano H, Halpern M, Hershkovitz D, Lossos A, Lerer I, Peretz T, Kariv R, Cohen S, Half EE, Magal N, Drasinover V, Wimmer K, Goldberg Y, Bercovich D, Levi Z.

Pediatr Blood Cancer. 2016 Mar;63(3):418-27. doi: 10.1002/pbc.25818. Epub 2015 Nov 6.

PMID:
26544533
34.

Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases.

Uryvaev A, Moskovitz M, Abdach-Bortnyak R, Hershkovitz D, Fried G.

Breast Cancer Res Treat. 2015 Aug;153(1):3-8. doi: 10.1007/s10549-015-3506-0. Epub 2015 Jul 24. Review.

PMID:
26206321
35.

Evidence for the initiation of decompression sickness by exposure to intense underwater sound.

Tal D, Shachar-Bener H, Hershkovitz D, Arieli Y, Shupak A.

J Neurophysiol. 2015 Sep;114(3):1521-9. doi: 10.1152/jn.00466.2015. Epub 2015 Jul 1.

36.

Clonal evolution models of tumor heterogeneity.

Shlush LI, Hershkovitz D.

Am Soc Clin Oncol Educ Book. 2015:e662-5. doi: 10.14694/EdBook_AM.2015.35.e662. Review.

37.

A deep penetrating facial congenital melanocytic tumor with bone involvement and ipsilateral eye blindness.

Bergman R, Ben-Arush MW, Bar-Shalom R, Gilboa M, Simon E, Hershkovitz D, Sabo E, Maly A, Gerami P, Goldsher D.

Am J Dermatopathol. 2015 Jan;37(1):e5-e11. doi: 10.1097/DAD.0000000000000048.

PMID:
25222197
38.

Frozen section examination may facilitate reconstructive surgery for mid and low rectal cancer.

Khoury W, Abboud W, Hershkovitz D, Duek SD.

J Surg Oncol. 2014 Dec;110(8):997-1001. doi: 10.1002/jso.23758. Epub 2014 Sep 2.

PMID:
25183166
39.

Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.

Vornicova O, Hershkovitz D, Yablonski-Peretz T, Ben-Itzhak O, Keidar Z, Bar-Sela G.

Oncologist. 2014 Sep;19(9):1006-7. doi: 10.1634/theoncologist.2014-0054. Epub 2014 Aug 1. No abstract available.

40.

Adenoma and carcinoma components in colonic tumors show discordance for KRAS mutation.

Hershkovitz D, Simon E, Bick T, Prinz E, Noy S, Sabo E, Ben-Izhak O, Vieth M.

Hum Pathol. 2014 Sep;45(9):1866-71. doi: 10.1016/j.humpath.2014.05.005. Epub 2014 May 28.

PMID:
24998492
41.

Correlation between the presence of KRAS mutation and the morphometric characteristics of colorectal carcinoma cell nuclei.

Greenberg A, Hershkovitz D, Sabo E.

Anal Quant Cytopathol Histpathol. 2014 Feb;36(1):23-31.

PMID:
24902368
42.

KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.

Hershkovitz D, Vlodavsky E, Simon E, Ben-Izhak O.

Pathol Int. 2013 Dec;63(12):611-4. doi: 10.1111/pin.12123. Review.

PMID:
24422958
43.

Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.

Avitan-Hersh E, Tatur S, Indelman M, Gepstein V, Shreter R, Hershkovitz D, Brick R, Bergman R, Tiosano D.

J Clin Endocrinol Metab. 2014 Jan;99(1):E132-6. doi: 10.1210/jc.2013-2813. Epub 2013 Dec 20.

PMID:
24243633
44.

[Molecular pathology - aspects in KRAS mutation analysis in colon carcinoma].

Hershkovitz D, Ben-lzhak O.

Harefuah. 2013 Jun;152(6):356-60, 367. Review. Hebrew.

PMID:
23885470
45.

Vestibular evoked myogenic potentials and habituation to seasickness.

Tal D, Hershkovitz D, Kaminski-Graif G, Wiener G, Samuel O, Shupak A.

Clin Neurophysiol. 2013 Dec;124(12):2445-9. doi: 10.1016/j.clinph.2013.05.016. Epub 2013 Jun 22.

PMID:
23800706
46.

Colonic perineuriomas with and without crypt serration: a comparative study.

Groisman GM, Hershkovitz D, Vieth M, Sabo E.

Am J Surg Pathol. 2013 May;37(5):745-51. doi: 10.1097/PAS.0b013e318277a1a9.

PMID:
23588369
47.

The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel.

Bar-Sela G, Hershkovitz D, Haim N, Kaidar-Person O, Shulman K, Ben-Izhak O.

Oncol Lett. 2013 Feb;5(2):559-563. Epub 2012 Nov 16.

48.

Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation.

Peerless Y, Simon E, Sabo E, Ben-Izhak O, Hershkovitz D.

Exp Mol Pathol. 2013 Apr;94(2):309-13. doi: 10.1016/j.yexmp.2013.01.001. Epub 2013 Jan 10.

PMID:
23313782
49.

Gastrointestinal stromal tumor of the ampulla of Vater.

Brauner E, Kuten J, Ben-Ishay O, Hershkovitz D, Kluger Y.

Isr Med Assoc J. 2012 Sep;14(9):588-9. No abstract available.

50.

Development of a computerized morphometry application for assessment of the tumor fraction in colon carcinoma tissue samples.

Hershkovitz T, Shenhav A, Sabo E, Ben-Izhak O, Hershkovitz D.

Appl Immunohistochem Mol Morphol. 2013 Jan;21(1):54-8. doi: 10.1097/PAI.0b013e318256d9bd.

PMID:
22595946

Supplemental Content

Loading ...
Support Center